CB Therapeutics, Inc.

Advanced synthetic biology for planet and human health

Claim My Business
Security Type
Crowd SAFE
Min Investment
Offering Date
January 24, 2023
Expected Close Date
April 30, 2023
Target Raise
No. Investors
Security Price
Number of Employees
Short Term Debt
Cost of Goods
Long Term Debt
Net Income

Company Description

at the intersection of pharmacology,
mental health, and sustainability.

Key Deal Facts

An innovative synthetic biology & cellular agriculture platform
Sustainable, efficient and zero carbon emissions
Backed by the leading biopharma for mental health treatments (Atai)
Specialized scientific team with more than 100 years of combined experience
Generating revenues since 2022 | Targeting profitability by end of Q1 2023*
Prolific patent portfolio with 7 granted and 13 pending patents
Raised more than $11M to date | $5M from Y Combinator

Management Team / Advisory Board Bios

Sher Butt

Jacob Vogan
Co-founder, Chief Scientific Officer and Board Member

Jim Wade, PhD
Director, Analytical Chemistry

Aaron Cantu, MS
Head of Fermentation and Downstream Processing

Laura Peiffer, PhD
Associate Director, Strain Engineering

Erin Scott, PhD
Associate Director, Microbiology

Tyler Huelsman
Senior Research Associate

Phu Kat Nwe
Scientist I – Strain Engineering

Thanos Karavokiris
VP, Operations

Tiffany Hurd
Business Development Lead

Pamela Vizanko
Sales Director

Stephanie Elliott
Office Manager
Amount Raised : $9,650
Reveal the Score by Voting
Not enough ratings to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.

Security Description

An equity crowdfunding specific version of a SAFE used by crowdfunding portal Republic. Upon conversion (if and when that happens), investors may receive special shares with limited rights that do not show up on a company’s cap table. The issuer may roll over and not convert shares at the next financing round causing investors to lose out on some upside.

Research Reports

No reports have been submitted

Become a Reporter